APA (7th ed.) Citation

FAM, S., K, T., T, B., A, P., D, A., TA, Z., . . . DW, G. (2023). Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. MedRxiv : the preprint server for health sciences. https://doi.org/10.1101/2023.11.09.23298321

Chicago Style (17th ed.) Citation

FAM, Saner, et al. "Concurrent RB1 Loss and BRCA-deficiency Predicts Enhanced Immunological Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma." MedRxiv : The Preprint Server for Health Sciences 2023. https://doi.org/10.1101/2023.11.09.23298321.

MLA (9th ed.) Citation

FAM, Saner, et al. "Concurrent RB1 Loss and BRCA-deficiency Predicts Enhanced Immunological Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma." MedRxiv : The Preprint Server for Health Sciences, 2023, https://doi.org/10.1101/2023.11.09.23298321.